Nafcillin + Doxycycline

The combination of **nafcillin** and **doxycycline** is a pairing of two different antibiotics that exhibit a significant drug interaction. Nafcillin is a penicillinase-resistant penicillin antibiotic typically used for staphylococcal infections, while doxycycline is a tetracycline antibiotic with broad-spectrum activity. When used together, **doxycycline may reduce the effectiveness of nafcillin**. This interaction is pharmacodynamic; doxycycline inhibits bacterial protein synthesis, which can interfere with the mechanism of nafcillin, which relies on bacterial cell wall synthesis. Healthcare providers generally avoid prescribing these antibiotics simultaneously due to this interaction. If co-administration is deemed necessary, it should be done with caution under direct medical supervision, potentially requiring dosage adjustments. **Individual Drug Profiles:** * **Nafcillin:** A semisynthetic antistaphylococcal penicillin. Primarily used for infections caused by methicillin-sensitive _Staphylococcus aureus_ (MSSA). Available in injectable forms. Common uses include bacteremia, skin and soft-tissue infections, respiratory tract infections, bone and joint infections, and infective endocarditis. * **Doxycycline:** A tetracycline antibiotic with broad-spectrum activity. Used for various bacterial infections, Lyme disease, and acne. Also possesses anti-inflammatory properties. Nearly completely absorbed after oral administration. **Interaction Mechanism:** Doxycycline's bacteriostatic action (inhibiting protein synthesis) can antagonize the bactericidal action of penicillins like nafcillin (inhibiting cell wall synthesis), particularly in infections where rapid bacterial growth is crucial for the penicillin's efficacy.